JoelChasSchererMD
Cardiology • North Waltham, MAVice President, Clinical Development. Immunotherapeutics
Dr. Scherer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Winter St, Ste 2
North Waltham, MA 02451Phone+1 317-652-1285
Education & Training
Stanford University School of MedicineClass of 1981
Certifications & Licensure
IN State Medical License 1994 - 2023
CA State Medical License 1987 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 143 citationsDouble-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 ...Joanne Sloan-Lancaster, Eyas Abu-Raddad, John Polzer, Jeffrey W. Miller, Joel C Scherer
Diabetes Care. 2013-03-20 - 269 citationsSafety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placeb...David W. Dodick, Peter J. Goadsby, Egilius L.H. Spierings, Joel C Scherer, Steven Sweeney
The Lancet. Neurology. 2014-09-01 - 26 citationsDeterminants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.Elliott M. Antman, Howard A. Cooper, Charles Michael Gibson, J.A. de Lemos, Carolyn H. McCabe
European Heart Journal. 2002-06-01
Journal Articles
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placeb...David W Dodick, Peter J Goadsby, Egilius L H Spierings, Joel C Scherer, Steven P Sweeney, David S Grayzel, Lancet Neurology, 8/11/2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
